Voices
The Tumor Microenvironment and CAR T-Cell Resistance – MASCC
MASCC/X

The Tumor Microenvironment and CAR T-Cell Resistance – MASCC

The Multinational Association of Supportive Care in Cancer (MASCC), shared  a post on LinkedIn:

“Now available: ‘Complex Persistent Opioid Dependence: Concept and Management‘ from Atrium Health Wake Forest Baptist Comprehensive Cancer Center Supportive Oncology Grand Rounds video series.

Watch now.”

Other articles about MASCC on OncoDaily.

cancer Cancer research CAR T-Cell Resistance CAR T-cell therapy CD19 CAR-T cells Cellular Therapy Diffuse Large B-Cell Lymphoma DLBCL Folate Receptor Beta FRβ FRβ CAR T Cells hematologic malignancies immune microenvironment immuno-oncology immunotherapy lymphoma M2 Macrophages macrophages MASCC monocytes Multinational Association of Supportive Care in Cancer OncoDaily Oncology Preclinical Research Refractory DLBCL Relapsed DLBCL TAMs The Multinational Association of Supportive Care in Cancer (MASCC) therapeutic resistance TME translational research tumor microenvironment tumor-associated macrophages Yan Leyfman